Gilead Sciences (GILD) PT Raised to $120 at BMO Capital
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $136.63 +0.56%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Gilead Sciences (NASDAQ: GILD) to $120.00 (from $115.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Galaxy Entertainment Group Ltd (27:HK) (GXYEF) PT Lowered to HK$43.60 at Macquarie
- JPMorgan Upgrades KCE Electronics PCL (KCE:TB) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
